North America Home Infusion Therapy Market - Key Players, Size, Trends, Opportunities, Growth Analysis to 2028

 

The North America home infusion therapy market is expected to grow from US$ 10,954.08 million in 2022 to US$ 18,112.18 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028

Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population is Driving North America Home Infusion Therapy Market

Chronic disorders such as cardiovascular, nutritional, and gastrointestinal disorders, rheumatoid arthritis, and neurological disorders affect the overall quality of life.

📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲@ https://www.businessmarketinsights.com/sample/BMIRE00028375

According to the World Health Organization (WHO), over 50% of the global population is estimated to suffer from at least one chronic disease. The Centers for Disease Control and Prevention (CDC) stated that 6 out of 10 people in the US suffered from at least one chronic disease in 2019. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” a large-scale multinational study published in 2021, ~40% of 73,076 adults surveyed from 33 countries in the world were suffering from a functional gastrointestinal disorder (GFID). Age-related gastrointestinal problems are more common in the elderly population, aged 64 and above.

📚𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐋𝐢𝐧𝐤 @ https://www.businessmarketinsights.com/reports/north-america-home-infusion-therapy-market

𝐓𝐡𝐞 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

B. Braun Melsungen AG

Baxter International Inc

Nipro Corp

Becton Dickinson and Co

Fresenius Kabi AG

ICU Medical Inc

JMS Co Ltd

Eitan Medical Ltd

Terumo Corp

Expanding Geriatric Population:

  • Aging is associated with a decline in physiological function, increasing susceptibility to chronic diseases.
  • The global elderly population is growing rapidly. The Global Ageing Survey 2019 indicates that the proportion of individuals aged 65 and above is projected to increase from 1 in 11 in 2019 to 1 in 6 by 2025.
  • In the United States, the number of Americans aged 65 and older is expected to more than double between 2016 and 2060, reaching over 98 million.
  • Globally the percentage of the elderly will grow from 15% to approximately 24% by 2060.
  • This demographic shift, combined with the increased prevalence of chronic diseases, is creating a substantial demand for home infusion therapy, enabling patients to receive necessary treatments in the comfort and convenience of their own homes.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

 

𝐀𝐮𝐭𝐡𝐨𝐫𝐬 𝐁𝐢𝐨:

𝐒𝐡𝐫𝐞𝐲𝐚 𝐏𝐚𝐰𝐚𝐫

𝐒𝐞𝐧𝐢𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐄𝐱𝐩𝐞𝐫𝐭


Comments

Popular posts from this blog

Europe Power Management IC Market Major Manufacturers, Trends, Demand, Share Analysis to 2028

North America Industrial Insulation Market Drivers, Opportunities, Trends, and Forecasts by 2028

Europe Food Contact Paper Market Analysis, Segments, Key Players, Drivers, Trends by Forecast 2022 to 2028